What is the molecular structure of BPC-157?
BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide: 15 amino acids arranged in the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Structural analyses published in peer-reviewed literature confirm the molecular formula as C₆₂H₉₈N₁₆O₂₂ with a molecular weight of 1419.53 g/mol and CAS number 137525-51-0 (PMID: 30915550). The peptide sequence originates from a partial region of human gastric juice protein — specifically a protective protein isolated from gastric mucosa. Several proline residues at positions 3, 4, 5, and 8 introduce structural rigidity that likely affects receptor binding geometry and resistance to proteolytic degradation. N-terminal glycine and C-terminal valine anchor the sequence at both ends. NMR spectroscopy studies in aqueous solution reveal a partially helical conformation, with the central region exhibiting more ordered secondary structure than the flexible termini (PMID: 22240337). Synthesis proceeds via solid-phase peptide synthesis using Fmoc chemistry, followed by preparative HPLC purification and lyophilization. The final product is a white to off-white lyophilized powder with water solubility.
For performance research applications, BPC-157's molecular profile — proline-dense central sequence, no disulfide bonds, documented acid stability — makes it a tractable subject for cytoprotection and cellular stress mechanism studies.
What is the origin of BPC-157?
BPC-157 derives from the amino acid sequence of a protective protein first isolated from human gastric juice. Research traced the discovery to studies on gastric cytoprotection in the early 1990s, identifying a protein fraction exhibiting protective properties in mucosal tissue models (PMID: 15629827). The specific 15-amino acid fragment was subsequently isolated as the minimal active sequence responsible for those protective effects. The name "Body Protection Compound" reflects the original gastric research context. Published studies document early characterization of protective effects in gastric tissue models, with later work extending investigation to other tissue systems (PMID: 16320866). The synthetic version replicates the naturally occurring sequence with high fidelity — unlike many purely artificial constructs, BPC-157 maps directly to a sequence found in human tissue. Published molecular biology confirms that the synthetic peptide exhibits equivalent physicochemical properties to the native fragment (PMID: 20309382).
Performance research labs studying connective tissue and vascular signaling mechanisms have incorporated BPC-157 as a research tool precisely because its gastric origin provides well-characterized structural context while its multi-system activity makes it relevant across diverse preclinical models.
What are the published mechanisms of action for BPC-157?
Published research characterizes BPC-157 through several intersecting mechanistic pathways. The nitric oxide (NO) system is a primary target: studies document effects on NO synthesis and eNOS activity in endothelial cell cultures and gastric tissue models (PMID: 35489163). Modulation of eNOS influences NO production, which governs vascular tone, blood flow regulation, and endothelial signaling networks.
In vitro studies also demonstrate interactions with the GABAergic system — specifically effects on GABA-A receptor function and neurotransmitter dynamics in neuronal cell cultures (PMID: 26809810). Dopaminergic pathway effects have been characterized separately, including modulation of dopamine synthesis and receptor activity in cell culture models. Growth factor signaling represents another well-documented pathway: interactions with VEGF, FGF, and downstream receptor cascades have been observed in fibroblast and endothelial cell culture systems (PMID: 30915550). BPC-157 also affects the prostaglandin system, modulating prostaglandin E2 synthesis and receptor signaling in epithelial cell cultures, and influences the NO-cGMP pathway and calcium signaling downstream of NO.
The multi-pathway profile makes BPC-157 a useful tool for dissecting cytoprotective mechanisms in performance-adjacent research contexts — particularly studies focused on vascular regulation, connective tissue cell biology, and cellular stress response.
What does published research show about BPC-157 and nitric oxide?
Published studies establish NO pathway modulation as a primary molecular mechanism for BPC-157 in preclinical models. Research in endothelial cell cultures demonstrates effects on eNOS expression and activity, with downstream consequences for NO production and vascular regulation (PMID: 35489163). The NO system governs vascular tone, platelet aggregation, and a range of cellular stress responses — making it mechanistically relevant for performance research contexts examining vascular biology.
Published molecular studies show that BPC-157 influences NO-mediated responses in gastric tissue models, with apparent effects on cytoprotective mechanisms against oxidative injury. The peptide appears to affect NO bioavailability through both synthetic and stabilizing mechanisms. Downstream of NO, cGMP pathway effects have been characterized: BPC-157 modulates cGMP production, which influences smooth muscle relaxation and platelet function in tissue culture models. Published mechanistic studies consistently identify NO pathway engagement as central to BPC-157's observed effects across preclinical systems.
How does BPC-157 affect growth factor pathways?
Research in fibroblast and endothelial cell cultures shows that BPC-157 affects VEGF expression and VEGF receptor signaling, influencing angiogenic responses in vitro (PMID: 32786122). The peptide appears to enhance VEGF-A production in cellular models, with potential downstream effects on vascular formation and tissue remodeling. FGF-2 signaling effects have also been documented: BPC-157 influences fibroblast proliferation and extracellular matrix production in culture, with evidence of FGF receptor and downstream MAP kinase pathway involvement.
EGF receptor phosphorylation and signaling in epithelial cell cultures have been characterized as well, with BPC-157 affecting cell migration and wound closure in scratch assay models. Published molecular studies frame growth factor pathway modulation as a core mechanism through which BPC-157 influences cell proliferation, migration, and tissue remodeling responses in preclinical systems (PMID: 30915550). These pathways are directly relevant to research examining angiogenesis, connective tissue dynamics, and cellular stress responses — all active areas in performance compound research.
What is known about BPC-157 and neurotransmitter systems?
Published research characterizes BPC-157 interactions with GABA, dopamine, and serotonin pathways. Studies in neuronal cell cultures demonstrate effects on GABA-A receptor function — specifically chloride channel conductance and GABAergic signaling — with evidence of receptor subunit expression and trafficking effects (PMID: 26809810). Dopaminergic pathway interactions have been separately characterized, including effects on dopamine synthesis, release, and transporter function in neuronal cultures. Serotonin system effects are documented but less extensively than GABA and dopamine interactions.
Published molecular research points to effects on neurotransmitter metabolism through synthetic enzyme modulation and effects on monoamine oxidase activity in biochemical assays. These neurotransmitter observations derive from cell culture and biochemical models — they provide mechanistic context for observed effects in preclinical systems rather than clinical conclusions. For performance research labs examining peptide effects across neurological and peripheral tissue systems, the multi-neurotransmitter profile establishes BPC-157 as a mechanistically complex compound worth rigorous characterization.
What is the amino acid sequence of BPC-157?
The BPC-157 sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val — a linear 15-residue arrangement. Single-letter notation: GEPPPGKPADDAGLV. Mass spectrometry and Edman degradation studies confirm this sequence (PMID: 22240337). Key structural features include: a proline-rich region (Pro-Pro-Pro) at positions 3–5 that introduces backbone rigidity; multiple acidic residues (Glu, Asp, Asp) affecting net charge and aqueous solubility; hydrophobic residues (Leu, Val, Ala) distributed toward the C-terminus; and an absence of cysteine, eliminating disulfide bond formation. N-terminal glycine contributes flexibility while C-terminal valine anchors a hydrophobic domain. Solid-phase synthesis replicates this sequence with high fidelity, though the proline-rich central region requires careful coupling conditions to prevent incomplete reactions. Circular dichroism studies indicate the peptide adopts random coil and partial helical conformations in solution, with the proline-rich segment potentially forming polyproline-type geometry.
Sequence verification via mass spectrometry is standard practice before employing BPC-157 in mechanistic research — Prove It Performance includes mass spec confirmation in the CoA accompanying every batch.
How does BPC-157 interact with cellular stress responses?
Published research demonstrates BPC-157 effects on oxidative stress, ER stress, and mitochondrial function pathways. Studies in epithelial cell cultures show effects on antioxidant enzyme expression — including superoxide dismutase and catalase — with downstream changes in cellular redox status (PMID: 24147114). The peptide modulates reactive oxygen species production and scavenging in oxidative stress models. Heat shock protein expression, including HSP70 and HSP90, is affected by BPC-157 in cellular stress models; these molecular chaperones protect against stress-induced protein damage.
ER stress pathway interactions have been documented as well, with BPC-157 affecting unfolded protein response markers in cell culture. Published mitochondrial studies report effects on membrane potential and ATP production, with apparent influence on mitochondrial biogenesis markers and dynamics. Taken together, these stress response pathways provide mechanistic context for the cytoprotective properties observed across tissue culture studies — a profile consistent with research interest in performance-adjacent compounds that affect cellular resilience at the molecular level.
What research applications does BPC-157 have?
Published research applications for BPC-157 span cytoprotective mechanism investigation, tissue repair biology, and cellular stress response characterization. Gastric tissue models use BPC-157 to study protective mechanisms against chemical injury and oxidative damage (PMID: 11929096). Wound healing applications examine fibroblast migration, collagen synthesis, and angiogenesis in tissue culture and explant models. Vascular research investigates endothelial cell function, angiogenic signaling, and vascular remodeling in vitro. Neuroscience applications use BPC-157 as a tool for studying neurotransmitter system modulation and neuronal stress responses in cell culture.
Tendon and ligament biology represents a particularly active area, with published work examining connective tissue cell responses and extracellular matrix production — directly relevant to performance compound research. Studies typically use BPC-157 at concentrations of 1–100 μg/mL in cell culture media, with experimental duration varying by design. All applications require research-grade compound with verified sequence and documented analytical characterization — HPLC purity and mass spectrometry identity confirmation are prerequisites for reproducible mechanistic work.
What is the current state of BPC-157 research?
Published BPC-157 research consists primarily of preclinical studies using cell cultures, tissue models, and biochemical assays. Review articles characterize the existing literature as mechanistically informative but preliminary — multiple pathways have been characterized, but rigorous validation at the clinical level is lacking (PMID: 24147114). The identified mechanisms include NO pathway modulation, growth factor signaling, neurotransmitter interactions, and cellular stress response effects, with documented activity across gastric, vascular, and neuronal systems.
Quality concerns in portions of the published literature include methodological limitations and replication gaps. Published systematic reviews call for standardized protocols and independent replication of key findings across laboratories. Research-grade BPC-157 from documented suppliers enables investigators to conduct mechanistic studies with well-characterized compound batches — a prerequisite for producing reproducible data and building a credible body of literature. That's the prove-it standard: documented purity, verified sequence, batch-specific CoA.
FAQ
What is the molecular weight of BPC-157?
The molecular weight of BPC-157 is 1419.53 g/mol (monoisotopic) or 1419.64 g/mol (average). Published mass spectrometry studies confirm this value with high accuracy (PMID: 22240337).
What is the CAS number for BPC-157?
The CAS Registry Number for BPC-157 is 137525-51-0. This identifier distinguishes it from related compounds and provides standardized reference across chemical databases and quality documentation.
How stable is BPC-157 during storage?
Lyophilized BPC-157 is stable at -20°C for 24+ months. In solution, the peptide is susceptible to oxidation and hydrolysis. Published stability studies recommend aliquoting into single-use volumes and storing at -20°C or -80°C (PMID: 30915550).
What concentration is used in cell culture research?
Published in vitro studies typically use BPC-157 at 0.1–100 μg/mL, with 1–10 μg/mL being most common. Concentration selection depends on cell type and experimental endpoint. Always verify viability at intended concentrations before initiating mechanistic assays.
Does BPC-157 form disulfide bonds?
No. BPC-157 contains no cysteine residues and cannot form disulfide bonds. This simplifies synthesis and handling compared to disulfide-containing peptides and the linear form is the active research species.
Research Use Only: All compounds sold by Prove It Performance are intended exclusively for laboratory research. Not for human or animal consumption. These products are not drugs, supplements, or food. Statements have not been evaluated by the FDA. Must be 21+ to purchase.